Safety Of Nanomicellar Vasoactive Intestinal Peptide In Mice-Implications For Pulmonary Arterial Hypertension

Safety Of Nanomicellar Vasoactive Intestinal Peptide In Mice-Implications For Pulmonary Arterial Hypertension

I Rubinstein - B63. EXPERIMENTAL MODELS IN PULMONARY …, 2012 - Am Thoracic Soc

... Unlike free VIP, plasma VIP concentration determined by ELISA (Bachem, Torrance, CA) peaked
2 h after subcutaneous injection of VIP-SSM in BALB/c mice. Formulation of VIP with SSM
increased the dose of the peptide at which a significant decrease in systemic arterial ...

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com